PrimeX News

Broker News

ExxonMobil (XOM) Price Forecast: Pullback Tests Breakout Structure
Thu, 21 May 2026 21:06:05 GMT
S&P 500 Forecast: Mixed US Data and Renko Support Keep Bulls in Control
Thu, 21 May 2026 21:00:32 GMT
Crude Oil Price Forecast: Triangle Compression Near Breakout Zone
Thu, 21 May 2026 20:58:40 GMT
Gold (XAU/USD) Price Forecast: Momentum Builds Inside Tightening Range
Thu, 21 May 2026 20:51:53 GMT
Natural Gas Price Forecast: Bull Pennant Faces Critical Retest
Thu, 21 May 2026 20:42:25 GMT
Top Three AI Infrastructure Stocks for 2026
Thu, 21 May 2026 20:12:08 GMT

ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 30 Apr 2026 13:08:34 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Mon, 13 Apr 2026 16:16:44 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 26 Mar 2026 21:25:31 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Mon, 16 Mar 2026 13:30:15 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT

How Renko Charts Filter Market Noise & Improve Trend Analysis
Sun, 10 May 2026 14:02:44 GMT
Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT
US Sector Rotation Strategy: Using the Business Cycle & RRG Charts to Find Market Leaders
Sun, 03 May 2026 16:49:46 GMT
Silver (XAG) Forecast: Weak Below 50-Day MA, Silver Analysis Signals More Downside
Tue, 21 Apr 2026 17:29:23 GMT
What Are Leveraged and Inverse ETFs? Risks, Rewards, and Key Strategies
Mon, 23 Mar 2026 23:55:30 GMT
Bollinger Bands Trading Strategies: How to Read Volatility, Identify Market Regimes, and Trade with a Statistical Edge
Fri, 13 Mar 2026 22:59:16 GMT

Advertisement

Advertisement

INDV

Indivior Pharmaceuticals, Inc. Common Stock

37.46

USD

Sponsored

-0.13

-0.35%

May 21, 16:00 UTC -4

Closed

exchange

After-Market

37.42

-0.04

-0.09%

INDV News & Forecasts

featured

Zacks Investment Research

Does Indivior Pharmaceuticals Inc. (INDV) Have the Potential to Rally 32.48% as Wall Street Analysts Expect?

featured

Zacks Investment Research

Indivior Pharmaceuticals Inc. (INDV) Is a Great Choice for 'Trend' Investors, Here's Why

featured

Zacks Investment Research

Bears are Losing Control Over Indivior Pharmaceuticals Inc. (INDV), Here's Why It's a 'Buy' Now

featured

Zacks Investment Research

Indivior Pharmaceuticals Inc. (INDV) is a Great Momentum Stock: Should You Buy?

featured

Zacks Investment Research

Indivior Pharmaceuticals Inc. (INDV) Upgraded to Strong Buy: Here's What You Should Know

featured

Zacks Investment Research

Wall Street Analysts Predict a 27.76% Upside in Indivior Pharmaceuticals Inc. (INDV): Here's What You Should Know

featured

Indivior Pharmaceuticals, Inc. (INDV) Q1 2026 Earnings Call Transcript

featured

Zacks Investment Research

Indivior Pharmaceuticals Inc. (INDV) Q1 Earnings and Revenues Beat Estimates

featured

Zacks Investment Research

How Much Upside is Left in Indivior Pharmaceuticals Inc. (INDV)? Wall Street Analysts Think 45.99%

featured

Indivior: Still Attractive After FY25 Earnings Beat

featured

Zacks Investment Research

Down 12.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Indivior Pharmaceuticals Inc. (INDV)

featured

Indivior Pharmaceuticals, Inc. (INDV) Q4 2025 Earnings Call Transcript

featured

Zacks Investment Research

Indivior Pharmaceuticals Inc. (INDV) Tops Q4 Earnings and Revenue Estimates

Advertisement

Advertisement

Advertisement